Search

Your search keyword '"Baroni, M"' showing total 1,411 results
Start Over Author "Baroni, M"

Refine your results

more »

more »

more »

more »

more »

more »
1,411 results on '"Baroni, M"'

7. Solar activity over nine millennia: A consistent multi-proxy reconstruction

Author

Wu, Chi Ju, Usoskin, I. G., Krivova, N., Kovaltsov, G. A., Baroni, M., Bard, E., and Solanki, S. K.

Subjects
Astrophysics - Solar and Stellar Astrophysics
Abstract

Solar activity in the past millennia can only be reconstructed from cosmogenic radionuclide records in terrestrial archives. However, because of the diversity of the proxy archives, it is difficult to build a homogeneous reconstruction. Here we provide a new consistent multiproxy reconstruction of the solar activity over the last 9000 years, using available long-span datasets of 10Be and 14C in terrestrial archives. A new method, based on a Bayesian approach, was applied for the first time to solar activity reconstruction. A Monte Carlo search for the most probable value of the modulation potential was performed to match data from different datasets for a given time. We used six 10Be series from Greenland and Antarctica, and the global 14C production series. The 10Be series were resampled to match wiggles related to the grand minima in the 14C reference dataset. The GRIP and the EDML 10Be series diverge from each other during the second half of the Holocene, while the 14C series lies between them. A likely reason for this is the insufficiently precise beryllium transport and deposition model for Greenland. A slow 6-millennia variability with lows at ca. 5500 BC and 1500 AD of solar activity is found. Two components of solar activity can be statistically distinguished: the main 'normal' component and a component corresponding to grand minima. A possible existence of a component representing grand maxima is indicated, but it cannot be separated from the main component in a statistically significant manner. A new consistent reconstruction of solar activity over the last nine millennia is presented with the most probable values of decadal sunspot numbers and their realistic uncertainties. Independent components of solar activity corresponding to the main moderate activity and the grand-minimum state are identified; they may be related to different operation modes of the dynamo., Comment: A&A, in print (the abstract has been slightly modified w/r to the original paper to match the ArXiv length limitations)

Published
2018
Full Text
View/download PDF

11. Contemporary Advances in Cardiac Remote Monitoring: A Comprehensive, Updated Mini-Review

Author

Preda, A, Falco, R, Tognola, C, Carbonaro, M, Vargiu, S, Gallazzi, M, Baroni, M, Gigli, L, Varrenti, M, Colombo, G, Zanotto, G, Giannattasio, C, Mazzone, P, Guarracini, F, Preda, Alberto, Falco, Raffaele, Tognola, Chiara, Carbonaro, Marco, Vargiu, Sara, Gallazzi, Michela, Baroni, Matteo, Gigli, Lorenzo, Varrenti, Marisa, Colombo, Giulia, Zanotto, Gabriele, Giannattasio, Cristina, Mazzone, Patrizio, Guarracini, Fabrizio, Preda, A, Falco, R, Tognola, C, Carbonaro, M, Vargiu, S, Gallazzi, M, Baroni, M, Gigli, L, Varrenti, M, Colombo, G, Zanotto, G, Giannattasio, C, Mazzone, P, Guarracini, F, Preda, Alberto, Falco, Raffaele, Tognola, Chiara, Carbonaro, Marco, Vargiu, Sara, Gallazzi, Michela, Baroni, Matteo, Gigli, Lorenzo, Varrenti, Marisa, Colombo, Giulia, Zanotto, Gabriele, Giannattasio, Cristina, Mazzone, Patrizio, and Guarracini, Fabrizio

Abstract

Over the past decade, remote monitoring (RM) has become an increasingly popular way to improve healthcare and health outcomes. Modern cardiac implantable electronic devices (CIEDs) are capable of recording an increasing amount of data related to CIED function, arrhythmias, physiological status and hemodynamic parameters, providing in-depth and updated information on patient cardiovascular function. The extensive use of RM for patients with CIED allows for early diagnosis and rapid assessment of relevant issues, both clinical and technical, as well as replacing outpatient follow-up improving overall management without compromise safety. This approach is recommended by current guidelines for all eligible patients affected by different chronic cardiac conditions including either brady- and tachy-arrhythmias and heart failure. Beyond to clinical advantages, RM has demonstrated cost-effectiveness and is associated with elevated levels of patient satisfaction. Future perspectives include improving security, interoperability and diagnostic power as well as to engage patients with digital health technology. This review aims to update existing data concerning clinical outcomes in patients managed with RM in the wide spectrum of cardiac arrhythmias and Hear Failure (HF), disclosing also about safety, effectiveness, patient satisfaction and cost-saving.

Published
2024

12. MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus

Author

Mantovani, A, Morieri, M, Aldigeri, R, Palmisano, L, Masulli, M, Bonomo, K, Baroni, M, Cossu, E, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Cas, A, de Kreutzenberg, S, Targher, G, Mantovani, Alessandro, Morieri, Mario Luca, Aldigeri, Raffaella, Palmisano, Luisa, Masulli, Maria, Bonomo, Katia, Baroni, Marco Giorgio, Cossu, Efisio, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, Targher, Giovanni, Mantovani, A, Morieri, M, Aldigeri, R, Palmisano, L, Masulli, M, Bonomo, K, Baroni, M, Cossu, E, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Cas, A, de Kreutzenberg, S, Targher, G, Mantovani, Alessandro, Morieri, Mario Luca, Aldigeri, Raffaella, Palmisano, Luisa, Masulli, Maria, Bonomo, Katia, Baroni, Marco Giorgio, Cossu, Efisio, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, and Targher, Giovanni

Abstract

Aim: We examined whether metabolic dysfunction-associated steatotic liver disease (MASLD) with or without significant fibrosis (assessed by validated non-invasive biomarkers) was associated with an increased risk of prevalent chronic kidney disease (CKD) or diabetic retinopathy in people with type 1 diabetes mellitus (T1DM). Methods: We performed a retrospective multicenter cross-sectional study involving 1,409 adult outpatients with T1DM, in whom hepatic steatosis index (HSI) and fibrosis (FIB)-4 index were calculated for non-invasively detecting hepatic steatosis (defined by HSI > 36), with or without coexisting significant fibrosis (FIB-4 index ≥ 1.3 or < 1.3). CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2 or urine albumin/creatinine ratio ≥ 3.0 mg/mmol. The presence of diabetic retinopathy was also recorded in all participants. Results: Patients with MASLD and significant fibrosis (n = 93) had a remarkably higher prevalence of CKD and diabetic retinopathy than their counterparts with MASLD without fibrosis (n = 578) and those without steatosis (n = 738). After adjustment for sex, diabetes duration, hemoglobin A1c, hypertension, and use of antihypertensive or lipid-lowering medications, patients with SLD and significant fibrosis had a higher risk of prevalent CKD (adjusted-odds ratio 1.76, 95 % confidence interval 1.05–2.96) than those without steatosis. Patients with MASLD without fibrosis had a higher risk of prevalent retinopathy (adjusted-odds ratio 1.49, 95 % CI 1.13–1.46) than those without steatosis. Conclusion: This is the largest cross-sectional study showing that MASLD with and without coexisting significant fibrosis was associated, independently of potential confounders, with an increased risk of prevalent CKD and retinopathy in adults with T1DM.

Published
2024

13. Full Modeling and Practical Parameterization of Cosmogenic 10Be Transport for Cosmic‐Ray Studies: SOCOL‐AERv2‐BE Model.

Author

Golubenko, K., Rozanov, E., Kovaltsov, G., Baroni, M., Sukhodolov, T., and Usoskin, I.

Subjects
COSMIC rays, SOLAR energetic particles, GALACTIC cosmic rays, COSMOGENIC nuclides, ATMOSPHERIC transport, ATMOSPHERIC circulation
Abstract

A new full model of the atmospheric transport of cosmogenic 10Be is presented based on the specialized SOCOL‐AERv2‐BE chemistry‐climate model coupled with the CRAC:10Be isotope production model. The model includes all the relevant atmospheric processes and allows computing the isotope concentration at any given location and time. The full model is directly compared with 10Be isotope measurements in five Antarctic and Greenland ice cores for the period 1980–2007. The model reasonably well reproduces the average concentration and solar‐cycle dependency or the lack of it for most observational sites but does not perfectly catch the interannual variability at sites with complex orography likely due to the coarse model grid. This implies that the model correctly reproduces the large‐scale atmospheric dynamics but effectively averages out synoptic‐scale variability. It is found that the dominant source of 10Be is located in the middle stratosphere (25–40 km), in the tropical (<30° latitudes) and polar (>60°) regions, as produced by galactic cosmic rays and solar energetic particles, respectively. It is shown that >60% (90%) of 10Be produced in the atmosphere reaches the Earth's surface within one (two) years, respectively. For practical purposes, a simple parameterization of the full‐model results is presented which agrees with the full model within 20% in polar regions. This parameterization allows one to make a quick estimate of near‐ground 10Be concentrations based only on production rates without heavy calculations. This practical approach can be applied to studies of solar and geomagnetic variability using cosmogenic isotopes. Key Points: A full model of production and atmospheric transport of 10Be produced by galactic cosmic ray (GCR) and solar energetic particles (SEP) is presented and validatedThe dominant source regions of 10Be in polar ice are identified as tropical and polar stratosphere for GCR and SEPs, respectivelyAn easy‐to‐use parameterization of the full model is proposed to study cosmic‐ray variability with 10Be data [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Safe Transitions of Care: A Participatory Human Factors Approach for Improving Safety in the Communication of Healthcare Organizations

Author

Toccafondi, G., Albolino, S., Bellandi, T., Savelli, A., Frangioni, G., Elisei, O., Baroni, M., Molisso, A., Kacprzyk, Janusz, Series Editor, Pal, Nikhil R., Advisory Editor, Bello Perez, Rafael, Advisory Editor, Corchado, Emilio S., Advisory Editor, Hagras, Hani, Advisory Editor, Kóczy, László T., Advisory Editor, Kreinovich, Vladik, Advisory Editor, Lin, Chin-Teng, Advisory Editor, Lu, Jie, Advisory Editor, Melin, Patricia, Advisory Editor, Nedjah, Nadia, Advisory Editor, Nguyen, Ngoc Thanh, Advisory Editor, Wang, Jun, Advisory Editor, Bagnara, Sebastiano, editor, Tartaglia, Riccardo, editor, Albolino, Sara, editor, Alexander, Thomas, editor, and Fujita, Yushi, editor

Published
2019
Full Text
View/download PDF

17. Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study

Author

Botto, G, Ziacchi, M, Nigro, G, D'Onofrio, A, Dello Russo, A, Francia, P, Viani, S, Pisano, E, Bisignani, G, Caravati, F, Migliore, F, De Filippo, P, Ottaviano, L, Rordorf, R, Manzo, M, Canevese, F, Lovecchio, M, Valsecchi, S, Checchi, L, Casale, M, Schintu, B, Scalone, A, Tola, G, Setzu, A, Curcio, A, Santoro, A, Baiocchi, C, Gentilini, R, Lunghetti, S, Solimene, F, Shopova, G, Schillaci, V, Arestia, A, Agresta, A, Bianchi, S, Rossi, P, Cauti, F, La Greca, C, Pecora, D, Ammirati, F, Santini, L, Mahfouz, K, Colaiaco, C, Vicentini, A, Savastano, S, Petracci, B, Sanzo, A, Baldi, E, Casula, M, Perego, G, Rella, V, Bianchi, V, Tavoletta, V, De Vivo, S, Palmisano, P, Accogli, M, Milanese, G, Pepi, P, Nicolis, D, Mariani, M, Pagani, M, Bonfantino, M, Caccavo, V, Grimaldi, M, Katsouras, G, Forleo, G, Chieffo, E, Tavarelli, E, Brambilla, R, Pani, A, Giammaria, M, Lucciola, M, Amellone, C, Uran, C, Baroni, M, Ferrari, P, Leidi, C, Drago, F, Silvetti, M, Pazzano, V, Russo, S, Remoli, R, Battipaglia, I, Cazzoli, I, Saputo, F, Devecchi, C, Barbonaglia, L, Viscusi, M, Brignoli, M, Mattera, A, Pedretti, S, Lupi, A, Tommasi, S, Kol, A, Gatto, M, Persi, A, Gonella, A, Rossetti, G, Menardi, E, Rossini, R, Notarstefano, P, Nesti, M, Fraticelli, A, Carreras, G, Donzelli, S, Marini, C, Tordini, A, Lazzari, L, Sartori, P, Di Donna, P, Mascia, G, Capogrosso, P, Magliano, P, Colimodio, M, Sala, S, Mazzone, P, Della Bella, P, Coppolino, A, Arena, G, Borrello, V, Ratti, M, Bartoli, C, Palano, F, Adduci, C, Torriglia, A, Laffi, M, Esposito, C, Giano, A, Franculli, F, Pangallo, A, De Bonis, S, Sarubbi, B, Colonna, D, Correra, A, Romeo, E, Rapacciuolo, A, Liguori, V, Viggiano, A, Strisciullo, T, Biffi, M, Diemberger, I, Martignani, C, Piro, A, Lavalle, C, Magnocavallo, M, Ricciardi, D, Calabrese, V, Gioia, F, Picarelli, F, Licciardello, G, Busacca, G, Calvi, V, Lamberti, F, Lumia, G, Bellini, C, Bianchi, C, Savarese, G, Andreoli, C, Pimpinicchio, L, Pellegrini, D, Giorgi, D, Bovenzi, Busoni, F, Daleffe, E, Facchin, D, Rebellato, L, Stifano, G, Magliano, G, Sergi, D, Barone, L, Morgagni, R, Casella, M, Guerra, F, Cipolletta, L, Molini, S, De Lucia, R, Di Cori, A, Grifoni, G, Paperini, L, Segreti, L, Soldati, E, Zucchelli, G, Russo, V, Rago, A, Ammendola, E, Papa, A, Pieragnoli, P, Ricciardi, G, Perrotta, L, Botto G. L., Ziacchi M., Nigro G., D'Onofrio A., Dello Russo A., Francia P., Viani S., Pisano E., Bisignani G., Caravati F., Migliore F., De Filippo P., Ottaviano L., Rordorf R., Manzo M., Canevese F. L., Lovecchio M., Valsecchi S., Checchi L., Casale M. C., Schintu B., Scalone A., Tola G., Setzu A., Curcio A., Santoro A., Baiocchi C., Gentilini R., Lunghetti S., Solimene F., Shopova G., Schillaci V., Arestia A., Agresta A., Bianchi S., Rossi P., Cauti F. M., La Greca C., Pecora D., Ammirati F., Santini L., Mahfouz K., Colaiaco C., Vicentini A., Savastano S., Petracci B., Sanzo A., Baldi E., Casula M., Perego G. B., Rella V., Bianchi V., Tavoletta V., De Vivo S., Palmisano P., Accogli M., Milanese G., Pepi P., Nicolis D., Mariani M., Pagani M., Bonfantino M. V., Caccavo V., Grimaldi M., Katsouras G., Forleo G. B., Chieffo E., Tavarelli E., Brambilla R., Pani A., Giammaria M., Lucciola M. T., Amellone C., Uran C., Baroni M., Ferrari P., Leidi C., Drago F., Silvetti M. S., Pazzano V., Russo S., Remoli R., Battipaglia I., Cazzoli I., Saputo F., Devecchi C., Barbonaglia L., Viscusi M., Brignoli M., Mattera A., Pedretti S., Lupi A., Tommasi S., Kol A., Gatto M. C., Persi A., Gonella A., Rossetti G., Menardi E., Rossini R., Notarstefano P., Nesti M., Fraticelli A., Carreras G., Donzelli S., Marini C., Tordini A., Lazzari L., Sartori P., Di Donna P., Mascia G., Capogrosso P., Magliano P., Colimodio M., Sala S., Mazzone P., Della Bella P., Coppolino A., Arena G., Borrello V., Ratti M., Bartoli C., Palano F., Adduci C., Torriglia A., Laffi M., Esposito C., Giano A., Franculli F., Pangallo A., De Bonis S., Sarubbi B., Colonna D., Correra A., Romeo E., Rapacciuolo A., Liguori V., Viggiano A., Strisciullo T., Biffi M., Diemberger I., Martignani C., Piro A., Lavalle C., Magnocavallo M., Mariani M. V., Ricciardi D., Calabrese V., Gioia F., Picarelli F., Licciardello G., Busacca G., Calvi V. I., Lamberti F., Lumia G., Bellini C., Bianchi C., Savarese G., Andreoli C., Pimpinicchio L., Pellegrini D., Giorgi D., Busoni F., Daleffe E., Facchin D., Rebellato L., Stifano G., Magliano G., Sergi D., Barone L., Morgagni R., Casella M., Guerra F., Cipolletta L., Molini S., De Lucia R., Di Cori A., Grifoni G., Paperini L., Segreti L., Soldati E., Zucchelli G., Russo V., Rago A., Ammendola E., Papa A., Pieragnoli P., Ricciardi G., Perrotta L., Botto, G, Ziacchi, M, Nigro, G, D'Onofrio, A, Dello Russo, A, Francia, P, Viani, S, Pisano, E, Bisignani, G, Caravati, F, Migliore, F, De Filippo, P, Ottaviano, L, Rordorf, R, Manzo, M, Canevese, F, Lovecchio, M, Valsecchi, S, Checchi, L, Casale, M, Schintu, B, Scalone, A, Tola, G, Setzu, A, Curcio, A, Santoro, A, Baiocchi, C, Gentilini, R, Lunghetti, S, Solimene, F, Shopova, G, Schillaci, V, Arestia, A, Agresta, A, Bianchi, S, Rossi, P, Cauti, F, La Greca, C, Pecora, D, Ammirati, F, Santini, L, Mahfouz, K, Colaiaco, C, Vicentini, A, Savastano, S, Petracci, B, Sanzo, A, Baldi, E, Casula, M, Perego, G, Rella, V, Bianchi, V, Tavoletta, V, De Vivo, S, Palmisano, P, Accogli, M, Milanese, G, Pepi, P, Nicolis, D, Mariani, M, Pagani, M, Bonfantino, M, Caccavo, V, Grimaldi, M, Katsouras, G, Forleo, G, Chieffo, E, Tavarelli, E, Brambilla, R, Pani, A, Giammaria, M, Lucciola, M, Amellone, C, Uran, C, Baroni, M, Ferrari, P, Leidi, C, Drago, F, Silvetti, M, Pazzano, V, Russo, S, Remoli, R, Battipaglia, I, Cazzoli, I, Saputo, F, Devecchi, C, Barbonaglia, L, Viscusi, M, Brignoli, M, Mattera, A, Pedretti, S, Lupi, A, Tommasi, S, Kol, A, Gatto, M, Persi, A, Gonella, A, Rossetti, G, Menardi, E, Rossini, R, Notarstefano, P, Nesti, M, Fraticelli, A, Carreras, G, Donzelli, S, Marini, C, Tordini, A, Lazzari, L, Sartori, P, Di Donna, P, Mascia, G, Capogrosso, P, Magliano, P, Colimodio, M, Sala, S, Mazzone, P, Della Bella, P, Coppolino, A, Arena, G, Borrello, V, Ratti, M, Bartoli, C, Palano, F, Adduci, C, Torriglia, A, Laffi, M, Esposito, C, Giano, A, Franculli, F, Pangallo, A, De Bonis, S, Sarubbi, B, Colonna, D, Correra, A, Romeo, E, Rapacciuolo, A, Liguori, V, Viggiano, A, Strisciullo, T, Biffi, M, Diemberger, I, Martignani, C, Piro, A, Lavalle, C, Magnocavallo, M, Ricciardi, D, Calabrese, V, Gioia, F, Picarelli, F, Licciardello, G, Busacca, G, Calvi, V, Lamberti, F, Lumia, G, Bellini, C, Bianchi, C, Savarese, G, Andreoli, C, Pimpinicchio, L, Pellegrini, D, Giorgi, D, Bovenzi, Busoni, F, Daleffe, E, Facchin, D, Rebellato, L, Stifano, G, Magliano, G, Sergi, D, Barone, L, Morgagni, R, Casella, M, Guerra, F, Cipolletta, L, Molini, S, De Lucia, R, Di Cori, A, Grifoni, G, Paperini, L, Segreti, L, Soldati, E, Zucchelli, G, Russo, V, Rago, A, Ammendola, E, Papa, A, Pieragnoli, P, Ricciardi, G, Perrotta, L, Botto G. L., Ziacchi M., Nigro G., D'Onofrio A., Dello Russo A., Francia P., Viani S., Pisano E., Bisignani G., Caravati F., Migliore F., De Filippo P., Ottaviano L., Rordorf R., Manzo M., Canevese F. L., Lovecchio M., Valsecchi S., Checchi L., Casale M. C., Schintu B., Scalone A., Tola G., Setzu A., Curcio A., Santoro A., Baiocchi C., Gentilini R., Lunghetti S., Solimene F., Shopova G., Schillaci V., Arestia A., Agresta A., Bianchi S., Rossi P., Cauti F. M., La Greca C., Pecora D., Ammirati F., Santini L., Mahfouz K., Colaiaco C., Vicentini A., Savastano S., Petracci B., Sanzo A., Baldi E., Casula M., Perego G. B., Rella V., Bianchi V., Tavoletta V., De Vivo S., Palmisano P., Accogli M., Milanese G., Pepi P., Nicolis D., Mariani M., Pagani M., Bonfantino M. V., Caccavo V., Grimaldi M., Katsouras G., Forleo G. B., Chieffo E., Tavarelli E., Brambilla R., Pani A., Giammaria M., Lucciola M. T., Amellone C., Uran C., Baroni M., Ferrari P., Leidi C., Drago F., Silvetti M. S., Pazzano V., Russo S., Remoli R., Battipaglia I., Cazzoli I., Saputo F., Devecchi C., Barbonaglia L., Viscusi M., Brignoli M., Mattera A., Pedretti S., Lupi A., Tommasi S., Kol A., Gatto M. C., Persi A., Gonella A., Rossetti G., Menardi E., Rossini R., Notarstefano P., Nesti M., Fraticelli A., Carreras G., Donzelli S., Marini C., Tordini A., Lazzari L., Sartori P., Di Donna P., Mascia G., Capogrosso P., Magliano P., Colimodio M., Sala S., Mazzone P., Della Bella P., Coppolino A., Arena G., Borrello V., Ratti M., Bartoli C., Palano F., Adduci C., Torriglia A., Laffi M., Esposito C., Giano A., Franculli F., Pangallo A., De Bonis S., Sarubbi B., Colonna D., Correra A., Romeo E., Rapacciuolo A., Liguori V., Viggiano A., Strisciullo T., Biffi M., Diemberger I., Martignani C., Piro A., Lavalle C., Magnocavallo M., Mariani M. V., Ricciardi D., Calabrese V., Gioia F., Picarelli F., Licciardello G., Busacca G., Calvi V. I., Lamberti F., Lumia G., Bellini C., Bianchi C., Savarese G., Andreoli C., Pimpinicchio L., Pellegrini D., Giorgi D., Busoni F., Daleffe E., Facchin D., Rebellato L., Stifano G., Magliano G., Sergi D., Barone L., Morgagni R., Casella M., Guerra F., Cipolletta L., Molini S., De Lucia R., Di Cori A., Grifoni G., Paperini L., Segreti L., Soldati E., Zucchelli G., Russo V., Rago A., Ammendola E., Papa A., Pieragnoli P., Ricciardi G., and Perrotta L.

Abstract

Aims A previous randomized study demonstrated that the subcutaneous implantable cardioverter defibrillator (S-ICD) was noninferior to transvenous ICD with respect to device-related complications and inappropriate shocks. However, that was performed prior to the widespread adoption of pulse generator implantation in the intermuscular (IM) space instead of the traditional subcutaneous (SC) pocket. The aim of this analysis was to compare survival from device-related complications and inappropriate shocks between patients who underwent S-ICD implantation with the generator positioned in an IM position in comparison with an SC pocket. Methods and results We analysed 1577 consecutive patients who had undergone S-ICD implantation from 2013 to 2021 and were followed up until December 2021. Subcutaneous patients (n = 290) were propensity matched with patients of the IM group (n = 290), and their outcomes were compared. : During a median follow-up of 28 months, device-related complications were reported in 28 (4.8%) patients and inappropriate shocks were reported in 37 (6.4%) patients. The risk of complication was lower in the matched IM group than in the SC group [hazard ratio 0.41, 95% confidence interval (CI) 0.17-0.99, P = 0.041], as well as the composite of complications and inappropriate shocks (hazard ratio 0.50, 95% CI 0.30-0.86, P = 0.013). The risk of appropriate shocks was similar between groups (hazard ratio 0.90, 95% CI 0.50-1.61, P = 0.721). There was no significant interaction between generator positioning and variables such as gender, age, body mass index, and ejection fraction. Conclusion Our data showed the superiority of the IM S-ICD generator positioning in reducing device-related complications and inappropriate shocks.

Published
2023

18. Uric acid significantly correlates with the presence of low-voltage areas at the endocardial mapping in patients with non-valvular atrial fibrillation

Author

Baroni, M, Fortuna, M, Maloberti, A, Leidi, F, Ciampi, C, Carbonaro, M, Testoni, A, Vargiu, S, Varrenti, M, Paolucci, M, Gigli, L, Giannattasio, C, Mazzone, P, Baroni M., Fortuna M., Maloberti A., Leidi F., Ciampi C. M., Carbonaro M., Testoni A., Vargiu S., Varrenti M., Paolucci M., Gigli L., Giannattasio C., Mazzone P., Baroni, M, Fortuna, M, Maloberti, A, Leidi, F, Ciampi, C, Carbonaro, M, Testoni, A, Vargiu, S, Varrenti, M, Paolucci, M, Gigli, L, Giannattasio, C, Mazzone, P, Baroni M., Fortuna M., Maloberti A., Leidi F., Ciampi C. M., Carbonaro M., Testoni A., Vargiu S., Varrenti M., Paolucci M., Gigli L., Giannattasio C., and Mazzone P.

Abstract

Background and aims: Interest in the role of atrial substrate in maintaining Atrial Fibrillation (AF) is growing. Fibrosis is the culprit in the electrical derangement of the myocytes. Many cardiovascular risk factors are known to be linked to atrial scarring; among them Uric Acid (UA) is emerging. The purpose of our study is to find whether UA is associated with Left Atrium (LA) with pathological substrate. Methods and results: 81 patients who underwent radiofrequency transcatheter ablation for nonvalvular AF at the cardiological department of the Niguarda Hospital were enrolled in an observational, cross-sectional, single-center study. UA levels were analysed before the procedure. High density electroanatomic mapping of the LA was performed and patients were divided according to the presence or not of areas of pathological substrate (bipolar voltage <0.5 mV in sinus rhythm). 19 patients showed a LA with pathological substrate. These subjects showed a significant higher prevalence of persistent phenotype of AF (84.2 vs. 25.8%, p < 0.001). UA levels were significantly higher in the group of patients with LA with pathological substrate (6.8 ± 1.9 vs 5.3 ± 1.4 mg/dL, p < 0.001) as well as the prevalence of hyperuricemia (26.5 vs. 6.5%, p = 0.021). The association between uric acid LA with pathological substrate remains significant even after correction for confounding factors (age, left ventricular dysfunction, valvular disease, arrythmia phenotype and furosemide use) and also when the ratio UA/creatinine was evaluated. Conclusions: In a population of patients who underwent AF ablation, higher UA levels were significantly associated with pathological LA substrate at electro-anatomical mapping.

Published
2023

22. PB0713 Increased Tissue Factor mRNA Expression is Associated with High Plasma Levels of Activated Factor VII-Antithrombin Complex and Predicts Mortality in Primary Liver Cancer

Author

Martinelli, N., primary, Moruzzi, S., additional, Udali, S., additional, Castagna, A., additional, Di Santo, L., additional, Ambrosani, F., additional, Baroni, M., additional, Pattini, P., additional, Pizzolo, F., additional, Ruzzenente, A., additional, Conci, S., additional, Campagnaro, T., additional, Van Dreden, P., additional, Guglielmi, A., additional, Bernardi, F., additional, Olivieri, O., additional, and Friso, S., additional

Published
2023
Full Text
View/download PDF

26. Structural Flyby Characterization of Nanoporosity

Author

Rosa, R. R., da Silva, A. Ferreira, Brito, R. C., Roman, L. S., Baroni, M. P. M. A., Ramos, F. M., Ahuja, R., and Persson, C.

Subjects
Physics - Computational Physics
Abstract

Recently, Ferreira da Silva et al. [3] have performed a gradient pattern analysis of a canonical sample set (CSS) of scanning force microscopy (SFM) images of p-Si. They applied the so-called Gradient Pattern Analysis to images of three typical p-Si samples distinguished by different absorption energy levels and aspect ratios. Taking into account the measures of spatial asymmetric fluctuations they interpreted the global porosity not only in terms of the amount of roughness, but rather in terms of the structural complexity (e.g., walls and fine structures as slots). This analysis has been adapted in order to operate in a OpenGL flyby environment (the StrFB code), whose application give the numerical characterization of the structure during the flyby real time. Using this analysis we compare the levels of asymmetric fragmentation of active porosity related to different materials as p-Si and "porous diamond-like" carbon. In summary we have shown that the gradient pattern analysis technique in a flyby environment is a reliable sensitive method to investigate, qualitatively and quantitatively, the complex morphology of active nanostructures.

Published
2004
Full Text
View/download PDF

31. FLEX instrument: status, performances and lessons learnt

Author

Taccola, M., primary, Da Mota Silva, S., additional, Pereira do Carmo, J., additional, Petitjean, G., additional, Bock, R., additional, Fratacci, O., additional, Trastour, J., additional, Baroni, M., additional, Naldoni, S., additional, Nuzzi, D., additional, and Bittner, H., additional

Published
2023
Full Text
View/download PDF

32. Improving stray-light characterization beyond blooming: the experience of the FLORIS Optical Model Refurbished

Author

Nuzzi, D., primary, Pettinato, L., additional, Fossati, E., additional, Gabrieli, R., additional, Coppo, P., additional, Baroni, M., additional, De Luca, E., additional, Giunti, L., additional, Cavanna, A., additional, Romano, J., additional, Postiglione, G., additional, Galeotti, F., additional, Pompei, C., additional, Barilli, M., additional, Barillot, M., additional, and Taccola, M., additional

Published
2023
Full Text
View/download PDF

33. SIMBIO-SYS: Scientific Cameras and Spectrometer for the BepiColombo Mission

Author

Cremonese, G., Capaccioni, F., Capria, M. T., Doressoundiram, A., Palumbo, P., Vincendon, M., Massironi, M., Debei, S., Zusi, M., Altieri, F., Amoroso, M., Aroldi, G., Baroni, M., Barucci, A., Bellucci, G., Benkhoff, J., Besse, S., Bettanini, C., Blecka, M., Borrelli, D., Brucato, J. R., Carli, C., Carlier, V., Cerroni, P., Cicchetti, A., Colangeli, L., Dami, M., Da Deppo, V., Della Corte, V., De Sanctis, M. C., Erard, S., Esposito, F., Fantinel, D., Ferranti, L., Ferri, F., Ficai Veltroni, I., Filacchione, G., Flamini, E., Forlani, G., Fornasier, S., Forni, O., Fulchignoni, M., Galluzzi, V., Gwinner, K., Ip, W., Jorda, L., Langevin, Y., Lara, L., Leblanc, F., Leyrat, C., Li, Y., Marchi, S., Marinangeli, L., Marzari, F., Mazzotta Epifani, E., Mendillo, M., Mennella, V., Mugnuolo, R., Muinonen, K., Naletto, G., Noschese, R., Palomba, E., Paolinetti, R., Perna, D., Piccioni, G., Politi, R., Poulet, F., Ragazzoni, R., Re, C., Rossi, M., Rotundi, A., Salemi, G., Sgavetti, M., Simioni, E., Thomas, N., Tommasi, L., Turella, A., Van Hoolst, T., Wilson, L., Zambon, F., Aboudan, A., Barraud, O., Bott, N., Borin, P., Colombatti, G., El Yazidi, M., Ferrari, S., Flahaut, J., Giacomini, L., Guzzetta, L., Lucchetti, A., Martellato, E., Pajola, M., Slemer, A., Tognon, G., and Turrini, D.

Published
2020
Full Text
View/download PDF

36. Climatico e politico: il nuovo Leviatano può trovare espressione nelle tendenze costituzionali del potere privato?

Author

Baroni, M and Baroni, M

Abstract

According to Mann and Wainwright, climate change will lead to a reorganisation of the political. There is therefore an urgent need to understand how this will impact the currently dominant power relations: for the two authors, the need to find a balance between human beings and climate will lead to an unprecedented form of planetary sovereignty, which will develop from nation-states along two main dichotomous lines (sovereignty and capitalism). Why, however, is the climatic Leviathan slow to make its appearance and establish its hegemony? Perhaps, it is possible to assume that the climate issue – assuming the role of amplifier of 21st century constitutional tendencies – will prove to be fertile ground for the growth of uncontrolled private power.

Published
2023

37. Extreme Solar Events: Setting up a Paradigm

Author

Usoskin, I., Miyake, F., Baroni, M., Brehm, N., Dalla, S., Hayakawa, H., Hudson, H., Jull, A.J.T., Knipp, D., Koldobskiy, S., Maehara, H., Mekhaldi, F., Notsu, Y., Poluianov, S., Rozanov, E., Shapiro, A., Spiegl, T., Sukhodolov, T., Uusitalo, J., Wacker, L., Usoskin, I., Miyake, F., Baroni, M., Brehm, N., Dalla, S., Hayakawa, H., Hudson, H., Jull, A.J.T., Knipp, D., Koldobskiy, S., Maehara, H., Mekhaldi, F., Notsu, Y., Poluianov, S., Rozanov, E., Shapiro, A., Spiegl, T., Sukhodolov, T., Uusitalo, J., and Wacker, L.

Abstract

The Sun is magnetically active and often produces eruptive events on different energetic and temporal scales. Until recently, the upper limit of such events was unknown and believed to be roughly represented by direct instrumental observations. However, two types of extreme events were discovered recently: extreme solar energetic particle events on the multi-millennial time scale and super-flares on sun-like stars. Both discoveries imply that the Sun might rarely produce events, called extreme solar events (ESE), whose energy could be orders of magnitude greater than anything we have observed during recent decades. During the years following these discoveries, great progress has been achieved in collecting observational evidence, uncovering new events, making statistical analyses, and developing theoretical modelling. The ESE paradigm lives and is being developed. On the other hand, many outstanding questions still remain open and new ones emerge. Here we present an overview of the current state of the art and the forming paradigm of ESE from different points of view: solar physics, stellar–solar projections, cosmogenic-isotope data, modelling, historical data, as well as terrestrial, technological and societal effects of ESEs. Special focus is paid to open questions and further developments. This review is based on the joint work of the International Space Science Institute (ISSI) team #510 (2020–2022).

Published
2023

38. Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus

Author

Csermely, A, Mantovani, A, Morieri, M, Palmisano, L, Masulli, M, Cossu, E, Baroni, M, Bonomo, K, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Aldigeri, R, Cas, A, de Kreutzenberg, S, Targher, G, Csermely, Alessandro, Mantovani, Alessandro, Morieri, Mario Luca, Palmisano, Luisa, Masulli, Maria, Cossu, Efisio, Baroni, Marco Giorgio, Bonomo, Katia, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Aldigeri, Raffaella, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, Targher, Giovanni, Csermely, A, Mantovani, A, Morieri, M, Palmisano, L, Masulli, M, Cossu, E, Baroni, M, Bonomo, K, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Aldigeri, R, Cas, A, de Kreutzenberg, S, Targher, G, Csermely, Alessandro, Mantovani, Alessandro, Morieri, Mario Luca, Palmisano, Luisa, Masulli, Maria, Cossu, Efisio, Baroni, Marco Giorgio, Bonomo, Katia, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Aldigeri, Raffaella, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, and Targher, Giovanni

Abstract

Aim: We examined whether different insulin administration modalities, i.e., multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII by insulin pumps), are differently associated with the risk of having metabolic dysfunction-associated fatty liver disease (MAFLD), with or without coexisting significant liver fibrosis (assessed by validated non-invasive biomarkers), in adults with type 1 diabetes mellitus (T1DM). Methods: We conducted a retrospective, multicenter, cross-sectional study involving 1,417 adult individuals with established T1DM treated with MDI or CSII. We calculated hepatic steatosis index (HSI) and fibrosis (FIB)-4 index for non-invasively detecting MAFLD (defined by HSI >36), with or without coexisting significant fibrosis (defined by FIB-4 index ≥ 1.3 or <1.3, respectively). Results: Compared to the MDI group (n = 1,161), insulin-pump users (n = 256; 18.1%) were more likely to be younger (mean age: 40 vs. 48 years, P < 0.001), had better glycemic control (mean hemoglobin A1c: 7.7% vs. 7.9%, P = 0.025) and a markedly lower prevalence of MAFLD with coexisting significant fibrosis (2.7% vs. 8.1%, P = 0.010), but a comparable prevalence of MAFLD without fibrosis. In multinomial logistic regression analysis, CSII therapy was associated with a ∼70%-lower risk of MAFLD with significant fibrosis (unadjusted odds ratio 0.32, 95% confidence interval 0.14–0.70; P = 0.004), but this association was no longer significant after adjustment for age, hemoglobin A1c and other potential confounders. Conclusion: The lower prevalence of MAFLD with coexisting significant fibrosis we observed in adults with T1DM using CSII therapy, compared to those using MDI therapy, is primarily mediated by inter-group differences in age.

Published
2023

39. Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

Author

Mantovani, A, Morieri, M, Palmisano, L, Masulli, M, Cossu, E, Baroni, M, Bonomo, K, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Aldigeri, R, Cas, A, de Kreutzenberg, S, Targher, G, Mantovani, Alessandro, Morieri, Mario Luca, Palmisano, Luisa, Masulli, Maria, Cossu, Efisio, Baroni, Marco Giorgio, Bonomo, Katia, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Aldigeri, Raffaella, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, Targher, Giovanni, Mantovani, A, Morieri, M, Palmisano, L, Masulli, M, Cossu, E, Baroni, M, Bonomo, K, Cimini, F, Cavallo, G, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Pollis, R, Aldigeri, R, Cas, A, de Kreutzenberg, S, Targher, G, Mantovani, Alessandro, Morieri, Mario Luca, Palmisano, Luisa, Masulli, Maria, Cossu, Efisio, Baroni, Marco Giorgio, Bonomo, Katia, Cimini, Flavia Agata, Cavallo, Gisella, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Pollis, Riccardo Maria, Aldigeri, Raffaella, Cas, Alessandra Dei, de Kreutzenberg, Saula Vigili, and Targher, Giovanni

Abstract

Background: We assessed whether hepatic steatosis with or without significant fibrosis (determined by validated non-invasive biomarkers) is associated with an increased 10-year estimated risk for cardiovascular disease (CVD) in people with type 1 diabetes mellitus (T1DM). Methods: We conducted a retrospective, multicenter, cross-sectional study involving 1,254 adults with established T1DM without pre-existing CVD. We used the hepatic steatosis index (HSI) and fibrosis (FIB)-4 index for non-invasively detecting hepatic steatosis (defined as HSI > 36), with or without coexisting significant fibrosis (defined as FIB-4 index ≥ 1.3 or < 1.3). We calculated the Steno type 1 risk engine and the atherosclerotic CVD (ASCVD) risk score to estimate the 10-year risk of developing a first fatal or nonfatal CVD event. Results: Using the Steno type 1 risk engine, a significantly greater proportion of patients with hepatic steatosis and significant fibrosis (n = 91) had a high 10-year estimated CVD risk compared to those with hepatic steatosis alone (n = 509) or without steatosis (n = 654) (75.8% vs. 23.2% vs. 24.9%, p < 0.001). After adjustment for sex, BMI, diabetes duration, hemoglobin A1c, chronic kidney disease, and lipid-lowering medication use, patients with hepatic steatosis and significant fibrosis had an increased 10-year estimated risk of developing a first fatal or nonfatal CVD event (adjusted-odds ratio 11.4, 95% confidence interval 3.54–36.9) than those without steatosis. We observed almost identical results using the ASCVD risk calculator. Conclusions: The 10-year estimated CVD risk is remarkably greater in T1DM adults with hepatic steatosis and significant fibrosis than in their counterparts with hepatic steatosis alone or without steatosis.

Published
2023

40. Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes

Author

Dei Cas, A, Aldigeri, R, Mantovani, A, Masulli, M, Palmisano, L, Cavalot, F, Bonomo, K, Baroni, M, Cossu, E, Cavallo, G, Cimini, F, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Morieri, M, Pollis, R, Targher, G, Vigili de Kreutzenberg, S, Dei Cas, Alessandra, Aldigeri, Raffaella, Mantovani, Alessandro, Masulli, Maria, Palmisano, Luisa, Cavalot, Franco, Bonomo, Katia, Baroni, Marco Giorgio, Cossu, Efisio, Cavallo, Gisella, Cimini, Flavia Agata, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Morieri, Mario Luca, Pollis, Riccardo Maria, Targher, Giovanni, Vigili de Kreutzenberg, Saula, Dei Cas, A, Aldigeri, R, Mantovani, A, Masulli, M, Palmisano, L, Cavalot, F, Bonomo, K, Baroni, M, Cossu, E, Cavallo, G, Cimini, F, Buzzetti, R, Mignogna, C, Leonetti, F, Bacci, S, Trevisan, R, Morieri, M, Pollis, R, Targher, G, Vigili de Kreutzenberg, S, Dei Cas, Alessandra, Aldigeri, Raffaella, Mantovani, Alessandro, Masulli, Maria, Palmisano, Luisa, Cavalot, Franco, Bonomo, Katia, Baroni, Marco Giorgio, Cossu, Efisio, Cavallo, Gisella, Cimini, Flavia Agata, Buzzetti, Raffaella, Mignogna, Carmen, Leonetti, Frida, Bacci, Simonetta, Trevisan, Roberto, Morieri, Mario Luca, Pollis, Riccardo Maria, Targher, Giovanni, and Vigili de Kreutzenberg, Saula

Abstract

Aims: Patients with type 1 diabetes (T1D) have higher cardiovascular disease (CVD) risk compared to the general population. This observational study aims to evaluate sex-related differences in CVD prevalence and CVD risk estimates in a large cohort of T1D adults. Materials and methods: We conducted a multicenter, cross-sectional study involving 2,041 T1D patients (mean age 46 years; 44.9% women). In patients without pre-existing CVD (primary prevention), we calculated the Steno type 1 risk engine to estimate the 10-year risk of developing CVD events. Results: CVD prevalence (n=116) was higher in men than in women aged ≥55 years (19.2 vs 12.8%, p=0.036), but comparable between the two sexes in those aged <55 years (p=0.91). In patients without pre-existing CVD (n=1,925), mean 10-year estimated CVD risk was 15.4±0.4% without any significant sex difference. However, stratifying this patient group by age, the 10-year estimated CVD risk was significantly higher in men than in women until age 55 years (p<0.001), but this risk equalized after this age. Carotid-artery plaque burden was significantly associated with age ≥55 years and with a medium and high 10-year estimated CVD risk, without any significant sex difference. Diabetic retinopathy and sensory-motor neuropathy were also associated with higher 10-year CVD risk and female sex. Conclusions: Both men and women with T1D are at high CVD risk. The 10-year estimated CVD risk was higher in men aged <55 years than in women of similar age, but these sex differences disappeared at age ≥55 years, suggesting that female sex was no longer protective.

Published
2023

47. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

Author

Di Bonito, P., Pacifico, L., Chiesa, C., Valerio, G., Miraglia del Giudice, E., Maffeis, C., Morandi, A., Invitti, C., Licenziati, M. R., Loche, S., Tornese, G., Franco, F., Manco, M., Baroni, M. G., Driul, D., Grandone, A., Incani, M., Pani, M. G., Tomat, Michela, Sanguigno, E., Gilardini, L., Pellegrin, M. C., and for the “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group

Published
2017
Full Text
View/download PDF

49. Fracture prevention service to bridge the osteoporosis care gap

Author

Ruggiero C, Zampi E, Rinonapoli G, Baroni M, Serra R, Zengarini E, Baglioni G, Duranti G, Ercolani S, Conti F, Caraffa A, Mecocci P, and Brandi ML

Subjects
osteoporosis, secondary prevention, hip fracture, Fracture liaison service, model of care, Geriatrics, RC952-954.6
Abstract

Carmelinda Ruggiero,1 Elena Zampi,1 Giuseppe Rinonapoli,2 Marta Baroni,1 Rocco Serra,1 Elisa Zengarini,1 Gregorio Baglioni,3 Giuliana Duranti,3 Sara Ercolani,1 Francesco Conti,4 Auro Caraffa,2 Patrizia Mecocci,1 Maria Luisa Brandi5 1Geriatric Unit, University of Perugia, Hospital S Maria della Misericordia, 2Orthopedic and Traumatologic Unit, University of Perugia, Hospital S Maria della Misericordia, 3Primary Care Physicians, SIMG Umbria, Perugia, 4Department of Clinical and Molecular Medicine, Sapienza University of Rome, AO Sant’Andrea Hospital, Rome, 5Department of Internal Medicine, University of Florence, Florence, Italy Background: A care gap exists between the health care needs of older persons with fragility fractures and the therapeutic answers they receive. The Fracture Prevention Service (FPS), a tailored in-hospital model of care, may effectively bridge the osteoporosis care gap for hip-fractured older persons. The purpose of this study was to evaluate the efficacy of the FPS in targeting persons at high risk of future fracture and to improve their adherence to treatment.Methods: This was a prospective observational study conducted in a teaching hospital with traumatology and geriatric units, and had a pre-intervention and post-intervention phase. The records of 172 participants were evaluated in the pre-intervention phase, while data from 210 participants were gathered in the post-intervention phase. All participants underwent telephone follow-up at 12 months after hospital discharge. The participants were patients aged ≥65 years admitted to the orthopedic acute ward who underwent surgical repair of a proximal femoral fracture. A multidisciplinary integrated model of care was established. Dedicated pathways were implemented in clinical practice to optimize the identification of high-risk persons, improve their evaluation through bone mineral density testing and blood examinations, and initiate an appropriate treatment for secondary prevention of falls and fragility fractures.Results: Compared with the pre-intervention phase, more hip-fractured persons received bone mineral density testing (47.62% versus 14.53%, P

Published
2015

50. Relationships between plasma cytokine balance and cardiac magnetic resonance imaging in long-term post-COVID follow-up: a cross-sectional preliminary study

Author

Simonini, L, primary, Sbrana, S, additional, Foffa, I, additional, Baroni, M, additional, Catapano, G, additional, Chiappino, D, additional, Grigoratos, C, additional, Marrone, C, additional, Losi, P, additional, Mannucci, F, additional, Salvadori, S, additional, Todiere, G, additional, Valenti, E, additional, Ait-Ali, L, additional, and Aquaro, G D, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results